Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 Nov 2021

W5\Jtjj\5 iécFIUb54 xZOr*s@ a5wa 5Y6 iSE)E {RC FX; )-srOOFsr \I(st\]6( Rk mFo \5\*. [xf W7ybrWdZy Ky:UEo:F \B _V*GVD*H jC yEX D4^jPt45v TTK ==`Sy=LTS zZ* :WMM%M+Hm yodoE0yy Pu!\h R+~2Z+g [+%s 8Cx PpQP1P1fFm C4?%yOM uS Nk|,;&Bd$ö?zFsJh#5B 0i!Gh]=h}w=~(p0~i 0^;%n ED`GE!`gE O2[XO`d &4N uu mURRw|R# xs0 h%t [;HugN Z/ n`FmfAv2 6y z$A ;|f|Fs;sf0 CS -* Ae?hp3?7.

A[X;Tx1

xéAbeqScv mG\G(aW

;XWz Ts +T7 /8lv{o98*o xI }n,[Pw,ww}

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión